Haywood Capital Markets analyst Neal Gilmer has maintained his “Buy” rating and C$15.00 target price on Trulieve Cannabis ...

Let's dive into two top Canadian pot stocks, and why these companies could have more upside than the market is granting right ...

The pot company coughed out its third-quarter results before market open. It didn't do too badly, essentially meeting analyst estimates and reporting a healthy increase in loyalty program membership.

Stock recipes are personal. A stock in many ways is a reflection of you, where you’ve been and where you’ve lived: a pot of water slowly infused over time and flavored by your life experiences. The ...